LDL-cholesterol Lowering Effect of a New Dietary Supplement

NCT03425630 · clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
20
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Ispharm srl